MARIMED INC.
MRMD- Exchange
- OTC
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001522767
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
2
- −1 vs. Q1 2026
- Total value $45.23K
Superinvestors holding MRMD
0
- None of the superinvestors held MRMD at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by MRMD insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 20264:30 PM ET | May 22, 2026 | Levine Jon RPresident and CEO | PPurchaseCommon stock | +60K | $0.0749 | +$4.5K | 21.31M | +0.3% | SEC |
| May 20, 20264:07 PM ET | May 20, 2026 | Levine Jon RPresident and CEO | PPurchaseCommon stock | +40K | $0.075 | +$3K | 21.25M | +0.2% | SEC |
| Dec 16, 20254:23 PM ET | Dec 12, 2025 | Shaw TimothyChief Operating Officer | PPurchaseCommon stock | +45.46K | $0.1071 | +$4.87K | 9.24M | +0.5% | SEC |
| Apr 29, 20247:07 PM ET | Apr 29, 2024 | Shaw TimothyChief Operating Officer | SSaleCommon stock | −40.21K | $0.2553 | −$10.26K | 8.55M | −0.5% | SEC10b5-1 |
| Apr 29, 20245:36 PM ET | Apr 29, 2024 | Levine Jon RPresident and CEO | SSaleCommon stock | −50.03K | $0.2553 | −$12.77K | 20.32M | −0.2% | SEC10b5-1 |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in MRMD at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Canton Hathaway, LLC | 645,100 | $45.22K | 0.01% | 00.0% | Unchanged |
| Game Plan Financial Advisors, LLC | 100 | $7 | 0.00% | 00.0% | Unchanged |